zobacz program

Transkrypt

zobacz program
IL S
DETA
T
C
A
T
CON
Conference Service Office:
Ewa Pankowska – Director
e-mail: [email protected]
tel. +48 22 858 32 45
Danuta Oraszek
+48 22 858 32 46
– Project Coordinator
fax +48 22 885 62 61
e-mail: [email protected]
Muszyƒska 25
02-916 Warsaw, Poland
Clinical Pharmacology Unit
National Institute of Cardiology
Alpejska 42
04-628 Warsaw, Poland
tel. +48 22 343 41 54
fax +48 22 343 45 18
e-mail: [email protected]
Department of Drug Chemistry
Warsaw Medical University
Banacha 1
02-097 Warsaw, Poland
tel. +48 22 572 06 30
fax +48 22 572 06 97
e-mail: [email protected]
HTS
HIGHLIG
Panel Discussions
Plenary Sessions
Commercial Exhibitions
Oral Presentations
Social Events
MEETING
ON
ATI
M
R
INFO
Dates:
Friday September 26 to
Saturday September 27, 2008
Location:
Hotel Hyatt Regency Warsaw
Belwederska 23
Warsaw, Poland
Official language:
English
Dates&Deadlines:
Start of registration 10 January 2008
Abstract submission deadline for oral presentation 31 May 2008
Notification of accepted communication 30 June 2008
Registration Deadline 15 August 2008
STRATEGIC SPONSOR
KEY SPONSORS:
w w w. i m m u n o t d m . c o m
Visit our website for updates, registration form, and call for other information!
International Conference
Therapeutic
Drug Monitoring
in Optimizing the
Immunosuppressive
Therapy
LC
E
W
E
M
O
AN
N
008
2
,
7
2
September 26-
rs
a
W
Supported by the International Association
of Therapeutic Drug Monitoring & Clinical Toxicology
and hosted by the Polish Pharmaceutical Society
w w w. i m m u n o t d m . c o m
ol
an
d
Dr Tomasz Pawiƒski, PharmD, PhD
O
UN
Dr Paweł K. Kunicki, PharmD, PhD
CE
ME
NT
Organizing Committee:
,P
w
a
RE
N
CE
T
MIT
M
O
IC C
SCIENTIF
EE
Co-Chairs:
Prof. David W. Holt
St. George's – University of London,
London, UK
Prof. Leslie M. Shaw
University of Pennsylvania Medical Center,
Philadelphia, USA
Dr Paweł K. Kunicki
National Institute of Cardiology,
Warsaw, Poland
Prof. Pierre Wallemacq
Cliniques Universitaires St Luc,
Brussels, Belgium
MAIN
IC
TOP
HE
harmacokinetic principles of immunosuppressive drugs – pharmacokinetic
P
monitoring in clinical practice
Dr Tomasz Pawiƒski
Medical University, Warsaw, Poland
Members:
IFIC
SCIENT
FT
SO
FE
N
O
C
harmacogenetics in solid organ transplantation: present knowledge
P
and future outlooks
Prof. Victor W. Armstrong
Georg-August-Universität, Göttingen,
Germany
Dr Magdalena Korecka
University of Pennsylvania Medical Center,
Philadelphia, USA
Progress in organ and tissue transplantation
Prof. Éliane M. Billaud
Hôpital Européen Georges Pompidou,
Paris, France
Prof. Pierre Marquet
University Hospital, Limoges, France
The role of IATDMCT – quality control in drug dosage and TDM
Prof. Magdalena Durlik
Medical University, Warsaw, Poland
Dr Teun van Gelder
Erasmus Medical Center,
Rotterdam, The Netherlands
E
MITT
ORGANIZING COM
linical application of population pharmacokinetic methods developed for
C
immunosuppressive drugs
onsensus report – the important role of documents in the unification of standards
C
of TDM of immunosuppressive drugs
Prof. Michael Oellerich
Georg-August-Universität,
Göttingen, Germany
uality control in Therapeutic Drug Monitoring – Immunosuppressive Drugs
Q
Proficiency Testing Scheme
Prof. Anna Wiela-Hojeƒska
Medical University, Wrocław, Poland
L imited sampling strategy models in pharmacokinetic studies for
immunosuppressive drugs in transplant patients
ew analytical methods for immunosuppressive drugs – chromatography,
N
immunoassays
E
Co-Chairs:
Paweł K. Kunicki, PharmD, PhD
National Institute of Cardiology
Warsaw, Poland
Members:
he place of generics in immunosuppressive therapy – (benefits and risks)
T
Bioequivalence criteria for immunosuppressive drugs
TDM and pharmacoeconomics – the tools of optimization therapy in transplantation
Tomasz Pawiƒski, PharmD, PhD
Medical University
Warsaw, Poland
Beata Gralak, PharmD,
Medical University
Warsaw, Poland
Jadwiga Majchrzak, MSc
Medical University
Warsaw, Poland
Magdalena Hurkacz, MSc, PhD
Medical University
Wrocław, Poland
Małgorzata Sobieszczaƒska-Małek, MD, PhD
National Institute of Cardiology
Warsaw, Poland
Magdalena Kuriata-Kordek, MD, PhD
Medical University
Wrocław, Poland
Therapeutic Drug Monitoring of immunosuppressive drugs in transplantation:
– cyclosporine A
– tacrolimus
– sirolimus
– everolimus
– mycophenolate mofetil
– mycophenolate sodium
harmacokinetic differences in immunosuppressive drugs dosage forms
P
– modified release products, generics, pro-drugs
Practical tools in TDM – Expert opinions – questions and answers
Short oral communications

Podobne dokumenty